Cargando…
Drug-Induced Intersticial Nephritis. Clinical Case
5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects. A rare side effect of this medicine is interstitial nephritis (IN). With discontinuation o...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Vilnius University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958646/ https://www.ncbi.nlm.nih.gov/pubmed/35474922 http://dx.doi.org/10.15388/Amed.2021.28.2.14 |
_version_ | 1784676989318201344 |
---|---|
author | Tekoriutė, Paulina Matuliauskaitė, Monika Jonaitis, Laimas Virginijus |
author_facet | Tekoriutė, Paulina Matuliauskaitė, Monika Jonaitis, Laimas Virginijus |
author_sort | Tekoriutė, Paulina |
collection | PubMed |
description | 5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects. A rare side effect of this medicine is interstitial nephritis (IN). With discontinuation of the drug the renal function usually restores. However, if damage has not been detected for a long time, irreversible changes may occur. In this article, we present a clinical case of mesalamine induced IN. A 56-year-old man who has had ulcerative colitis for 20 years, was admitted due to mesalamine induced acute renal failure. A year before, the patient had been diagnosed with mesalamine-induced interstitial nephritis and the treatment with mesalamine was discontinued. The symptoms of ulcerative colitis worsened, and the patient independently decided to start taking mesalamine, which resulted in worsening of his health condition and impaired renal function. Mesalamine has been discontinued, additional treatment for acute kidney failure has been administered including hemodialysis. Renal function recovered and the patient was released for further treatment of ulcerative colitis and monitoring of renal function. |
format | Online Article Text |
id | pubmed-8958646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Vilnius University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89586462022-04-25 Drug-Induced Intersticial Nephritis. Clinical Case Tekoriutė, Paulina Matuliauskaitė, Monika Jonaitis, Laimas Virginijus Acta Med Litu Case Studies 5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects. A rare side effect of this medicine is interstitial nephritis (IN). With discontinuation of the drug the renal function usually restores. However, if damage has not been detected for a long time, irreversible changes may occur. In this article, we present a clinical case of mesalamine induced IN. A 56-year-old man who has had ulcerative colitis for 20 years, was admitted due to mesalamine induced acute renal failure. A year before, the patient had been diagnosed with mesalamine-induced interstitial nephritis and the treatment with mesalamine was discontinued. The symptoms of ulcerative colitis worsened, and the patient independently decided to start taking mesalamine, which resulted in worsening of his health condition and impaired renal function. Mesalamine has been discontinued, additional treatment for acute kidney failure has been administered including hemodialysis. Renal function recovered and the patient was released for further treatment of ulcerative colitis and monitoring of renal function. Vilnius University Press 2021 2021-08-11 /pmc/articles/PMC8958646/ /pubmed/35474922 http://dx.doi.org/10.15388/Amed.2021.28.2.14 Text en Copyright © 2021 Paulina Tekoriutė, Monika Matuliauskaitė, Laimas Virginijus Jonaitis. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Case Studies Tekoriutė, Paulina Matuliauskaitė, Monika Jonaitis, Laimas Virginijus Drug-Induced Intersticial Nephritis. Clinical Case |
title | Drug-Induced Intersticial Nephritis. Clinical Case |
title_full | Drug-Induced Intersticial Nephritis. Clinical Case |
title_fullStr | Drug-Induced Intersticial Nephritis. Clinical Case |
title_full_unstemmed | Drug-Induced Intersticial Nephritis. Clinical Case |
title_short | Drug-Induced Intersticial Nephritis. Clinical Case |
title_sort | drug-induced intersticial nephritis. clinical case |
topic | Case Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958646/ https://www.ncbi.nlm.nih.gov/pubmed/35474922 http://dx.doi.org/10.15388/Amed.2021.28.2.14 |
work_keys_str_mv | AT tekoriutepaulina druginducedintersticialnephritisclinicalcase AT matuliauskaitemonika druginducedintersticialnephritisclinicalcase AT jonaitislaimasvirginijus druginducedintersticialnephritisclinicalcase |